Andojon, Ruth .

HRN: 28-21-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/09/2025
12/21/2025
IV
4.5g
Q8h
T/C Intraabdominal Infection
Checking Final Appropriateness 
12/20/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/20/2025
12/26/2025
IV
500mg
Q8
SP Exlap
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: